NCT00606060View on ClinicalTrials.gov

BAY14-2222 Continuous Infusion in Surgeries

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

May 31, 2005

Conditions

Hemophilia

Interventions

DRUG

Kogenate (BAY14-2222)

100 IU/mL (250 IU/vial nominal potency) continuous infusion over 6-11 days in 12 patients. 400 IU/mL (1000 IU/vial nominal potency) continuous infusion over 6-11days in 3 patients.

Trial Locations (1)

52621

Tel Litwinsky